حاوی 49 اسلاید متنی و تصویری به زبان انگلیسی که به صورت بصری تشخیص آزمایشگاهی سل فعال و نهفته را تشریح می کند One third of the world’s population is infected with tuberculosis and its incidence is increasing. Systemic
glucocorticoids are the mainstay of immunosuppressive therapy for immunobullous diseases and collagen
vascular diseases in dermatology. Patients who are given prolonged glucocorticoid therapy may be at risk
for both the acquisition of primary tuberculosis and the reactivation of nonactive tuberculosis. The purpose
of this article is to highlight the importance of screening for tuberculosis and its management in this group
of patients, as there are no published guidelines in the dermatology literature on this subject. We summarize
the methods used for tuberculosis screening, give an account of treatment regimens for the various types
of tuberculosis infection, and suggest a practical approach to screening and management of tuberculosis in
patients receiving long-term glucocorticoid therapy. (J Am Acad Dermatol 2003;49:91-5.)
Abstract Tuberculosis (TB) has resurged as a major public
health problem in the United States, but there is minimal
information on the public’s knowledge of TB. The general
population must become aware of the seriousness of the
reemergence of TB. Using data from the National Health
Interview Survey Supplement, this study examined knowledge
and perceived risk of TB of 14,727 U.S. respondents. Results
demonstrated some general knowledge of TB, several misconceptions,
and low concern regarding their risk of contracting TB.
Only 10.2% of the respondents perceived risk for themselves.
Respondents reported perceived knowledge of TB at a high level,
while their actual knowledge was lower. Gender, education,
income, and ethnicity were associated with knowledge and
perceived risk. Older people responded correctly to questions
about TB knowledge more often than younger people. Conclusions
were that public health nursing efforts need to be redirected
toward health education regarding TB risk and spread, complementing
existing screening and therapy programs.